![Kenji Kuramoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenji Kuramoto
Vorsitzender bei PHOENIXBIO CO., LTD.
Vermögen: 107 295 $ am 31.05.2024
Aktive Positionen von Kenji Kuramoto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHOENIXBIO CO., LTD. | Vorsitzender | 28.06.2018 | - |
Direktor/Vorstandsmitglied | 01.11.2005 | 28.06.2018 | |
Präsident | 01.11.2005 | 28.06.2018 |
Karriereverlauf von Kenji Kuramoto
Ehemalige bekannte Positionen von Kenji Kuramoto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Institute of Immunology Co., Ltd.
![]() Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | 01.01.2006 | 01.01.2006 |
Präsident | - | 01.01.2006 | |
PhoenixBio USA Corp.
![]() PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Part of PhoenixBio Co., Ltd., PhoenixBio USA Corp. develops technologies for mass propagation of human cells into laboratory animals. The company is based in New York, NY. Yoshio Morikawa has been the CEO of the company since 2015. | Vorsitzender | 01.06.2012 | - |
Sanwa Starch Co., Ltd.
![]() Sanwa Starch Co., Ltd. Agricultural Commodities/MillingProcess Industries Sanwa Starch Co., Ltd. manufactures and processes starch and starch products. The firm also manufactures sugar and glucose-based products. The company was founded by Seiichi Morimoto on January 9, 1947 and is headquartered in Kashihara, Japan. | Corporate Officer/Principal | 01.01.1995 | - |
Statistik
International
Japan | 4 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 2 |
Chairman | 2 |
President | 2 |
Sektoral
Commercial Services | 3 |
Process Industries | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHOENIXBIO CO., LTD. | Commercial Services |
Private Unternehmen | 3 |
---|---|
Sanwa Starch Co., Ltd.
![]() Sanwa Starch Co., Ltd. Agricultural Commodities/MillingProcess Industries Sanwa Starch Co., Ltd. manufactures and processes starch and starch products. The firm also manufactures sugar and glucose-based products. The company was founded by Seiichi Morimoto on January 9, 1947 and is headquartered in Kashihara, Japan. | Process Industries |
Institute of Immunology Co., Ltd.
![]() Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Health Technology |
PhoenixBio USA Corp.
![]() PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Part of PhoenixBio Co., Ltd., PhoenixBio USA Corp. develops technologies for mass propagation of human cells into laboratory animals. The company is based in New York, NY. Yoshio Morikawa has been the CEO of the company since 2015. | Commercial Services |
- Börse
- Insiders
- Kenji Kuramoto
- Erfahrung